Cambridge, MA, United States of America

Jordane Dimidschstein

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Broad Institute, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jordane Dimidschstein. Retrieved from https://idiyas.com/inventor/jordane-dimidschstein-oc9nzuku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jordane Dimidschstein: Inventor in Neuroscience

Introduction

Jordane Dimidschstein is an inventor based in Cambridge, Massachusetts. His work is associated with The Broad Institute, Inc., and his patent activity includes an invention focused on neuronal excitability and Dravet syndrome.

Latest Patents

Dimidschstein is listed as an inventor on 1 patent: “Interneuron-Specific Therapeutics for Normalizing Neuronal Cell Excitability and Treating Dravet Syndrome.” The patent concerns therapeutic approaches aimed at regulating neuronal cell excitability and treating Dravet syndrome.

Career Highlights

His listed patent reflects work at the intersection of neuroscience and therapeutic development. The invention’s focus is on interneuron-specific approaches to addressing abnormal neuronal excitability.

Collaborations

Dimidschstein’s listed coworkers include Gordon Fishell and Orrin Devinsky. Their names are associated with his patent-related work.

Conclusion

Jordane Dimidschstein’s patent activity highlights an effort to develop targeted therapeutic strategies for neuronal excitability and Dravet syndrome.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…